Patterns of Opioid Use Among Patients With Inflammatory Bowel Disease: Do We Need Better Disease Control or Multidisciplinary Interventions?
作者信息
Barnes Edward L
机构信息
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
出版信息
Crohns Colitis 360. 2020 Feb 14;2(1):otaa010. doi: 10.1093/crocol/otaa010. eCollection 2020 Jan.
Abstract
摘要
相似文献
1
Patterns of Opioid Use Among Patients With Inflammatory Bowel Disease: Do We Need Better Disease Control or Multidisciplinary Interventions?
Crohns Colitis 360. 2020 Feb 14;2(1):otaa010. doi: 10.1093/crocol/otaa010. eCollection 2020 Jan.
2
Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease.
Aliment Pharmacol Ther. 2021 Mar;53(6):704-711. doi: 10.1111/apt.16269. Epub 2021 Jan 26.
3
Opioid Use in Patients With Inflammatory Bowel Disease.
Crohns Colitis 360. 2020 Feb 14;2(1):otaa009. doi: 10.1093/crocol/otaa009. eCollection 2020 Jan.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S42-S48. doi: 10.1093/jcag/gwy048. Epub 2018 Nov 2.
5
The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2022 Dec 1;28(12):1904-1914. doi: 10.1093/ibd/izac021.
6
Educational Interventions for Newly Diagnosed Patients With Inflammatory Bowel Disease: A Scoping Review.
Gastroenterol Nurs. 2023;46(1):30-40. doi: 10.1097/SGA.0000000000000688. Epub 2023 Jan 10.
7
Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Sep 1;29(9):1355-1361. doi: 10.1093/ibd/izac218.
8
Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2064-2071.e1. doi: 10.1016/j.cgh.2020.07.020. Epub 2020 Jul 16.
9
Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol. 2021 May;19(5):895-907.e4. doi: 10.1016/j.cgh.2020.08.041. Epub 2020 Aug 21.
10
Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
Adv Ther. 2021 Jul;38(7):3589-3621. doi: 10.1007/s12325-021-01766-y. Epub 2021 Jun 4.
引用本文的文献
1
Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006-2021.
Aliment Pharmacol Ther. 2025 Aug;62(4):440-452. doi: 10.1111/apt.70203. Epub 2025 Jun 1.
2
GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release.
Pain. 2025 Mar 1;166(3):596-613. doi: 10.1097/j.pain.0000000000003399. Epub 2024 Oct 3.
3
Trends in hospital admissions and mortality among inflammatory bowel disease patients with substance use disorder: a 10-year United States nationwide analysis.
Proc (Bayl Univ Med Cent). 2023 May 3;36(4):427-433. doi: 10.1080/08998280.2023.2204535. eCollection 2023.
本文引用的文献
1
Opioid Use in Patients With Inflammatory Bowel Disease.
Crohns Colitis 360. 2020 Feb 14;2(1):otaa009. doi: 10.1093/crocol/otaa009. eCollection 2020 Jan.
2
Exposure to Intravenous Opioids Is Associated With Future Exposure to Opioids in Hospitalized Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2269-2278.e3. doi: 10.1016/j.cgh.2019.12.024. Epub 2019 Dec 27.
3
Prescription Opioids induce Gut Dysbiosis and Exacerbate Colitis in a Murine Model of Inflammatory Bowel Disease.
J Crohns Colitis. 2020 Jul 9;14(6):801-817. doi: 10.1093/ecco-jcc/jjz188.
4
Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease.
Dig Dis Sci. 2020 Aug;65(8):2379-2387. doi: 10.1007/s10620-019-05968-x. Epub 2019 Nov 22.
5
Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
Dig Dis Sci. 2020 Jun;65(6):1777-1783. doi: 10.1007/s10620-019-05906-x. Epub 2019 Oct 25.
6
Perioperative and Postoperative Management of Patients With Crohn's Disease and Ulcerative Colitis.
Clin Gastroenterol Hepatol. 2020 May;18(6):1356-1366. doi: 10.1016/j.cgh.2019.09.040. Epub 2019 Oct 4.
7
Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.
Aliment Pharmacol Ther. 2019 Jan;49(1):74-83. doi: 10.1111/apt.15023. Epub 2018 Nov 14.
8
The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2018 Jun 8;24(7):1380-1388. doi: 10.1093/ibd/izy040.
9
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.
J Crohns Colitis. 2018 Aug 29;12(9):1030-1035. doi: 10.1093/ecco-jcc/jjy062.
10
Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1777-1785. doi: 10.1016/j.cgh.2018.04.007. Epub 2018 Apr 12.
Zotero 插件